Table 1.
Common and clinical characteristics of the participants (N = 40).
| Variables | TENS Group (n = 20) | Placebo Group (n = 20) | p-Value a |
|---|---|---|---|
| Sex | |||
| Male | 14 | 12 | 0.741 a |
| Female | 6 | 8 | |
| Age (years) | 53.1 ± 7.9 a | 52.7 ± 11.5 | 0.886 b |
| Weight (kg) | 63.2 ± 9.0 | 65.9 ± 8.2 | 0.325 b |
| Height (cm) | 165.5 ± 9.4 | 166.7 ± 10.5 | 0.695 b |
| Stroke type | |||
| Ischemic | 13 | 11 | 0.748 a |
| Hemorrhagic | 7 | 9 | |
| Post-stroke duration (months) | 6.8 ± 2.5 | 7.0 ± 2.6 | 0.758 b |
Values are expressed as mean ± standard deviation. a Chi-square test. b Independent t-test. Transcutaneous electrical nerve stimulation (TENS).